A detailed history of Summit Trail Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Summit Trail Advisors, LLC holds 5,177 shares of NVS stock, worth $509,675. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,177
Previous 5,553 6.77%
Holding current value
$509,675
Previous $591,000 0.68%
% of portfolio
0.01%
Previous 0.02%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$106.13 - $120.89 $39,904 - $45,454
-376 Reduced 6.77%
5,177 $595,000
Q2 2024

Aug 13, 2024

BUY
$92.57 - $107.37 $88,496 - $102,645
956 Added 20.8%
5,553 $591,000
Q1 2024

Apr 23, 2024

BUY
$95.27 - $108.47 $26,103 - $29,720
274 Added 6.34%
4,597 $444,000
Q4 2023

Feb 06, 2024

BUY
$92.27 - $101.54 $63,204 - $69,554
685 Added 18.83%
4,323 $436,000
Q3 2023

Oct 30, 2023

SELL
$94.73 - $105.13 $59,016 - $65,495
-623 Reduced 14.62%
3,638 $370,000
Q2 2023

Jul 25, 2023

BUY
$92.52 - $104.91 $66,244 - $75,115
716 Added 20.2%
4,261 $429,000
Q1 2023

May 04, 2023

BUY
$80.03 - $92.81 $283,706 - $329,011
3,545 New
3,545 $326,000
Q1 2022

May 16, 2022

SELL
$80.11 - $90.62 $275,978 - $312,185
-3,445 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$79.7 - $88.13 $274,566 - $303,607
3,445 New
3,445 $301,000
Q4 2018

Feb 13, 2019

SELL
$73.66 - $82.02 $312,907 - $348,420
-4,248 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$66.94 - $77.43 $46,054 - $53,271
688 Added 19.33%
4,248 $366,000
Q2 2018

Aug 10, 2018

SELL
$64.91 - $73.36 $1.26 Million - $1.43 Million
-19,460 Reduced 84.54%
3,560 $269,000
Q1 2018

May 22, 2018

SELL
$70.39 - $84.15 $103 Million - $123 Million
-1,460,058 Reduced 98.45%
23,020 $1.48 Million
Q1 2018

May 21, 2018

BUY
$70.39 - $84.15 $103 Million - $123 Million
1,464,531 Added 7896.32%
1,483,078 $1.48 Million
Q4 2017

Feb 14, 2018

BUY
$72.33 - $77.64 $1.34 Million - $1.44 Million
18,547
18,547 $1.68 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Summit Trail Advisors, LLC Portfolio

Follow Summit Trail Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Trail Advisors, LLC with notifications on news.